These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21990414)
1. Prognostic impact of body mass index stratified by smoking status in patients with esophageal adenocarcinoma. Yoon HH; Lewis MA; Shi Q; Khan M; Cassivi SD; Diasio RB; Sinicrope FA J Clin Oncol; 2011 Dec; 29(34):4561-7. PubMed ID: 21990414 [TBL] [Abstract][Full Text] [Related]
2. Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival. Spreafico A; Coate L; Zhai R; Xu W; Chen ZF; Chen Z; Patel D; Tse B; Brown MC; Heist RS; Dodbiba L; Teichman J; Kulke M; Su L; Eng L; Knox J; Wong R; Darling GE; Christiani DC; Liu G Cancer Epidemiol; 2017 Apr; 47():28-34. PubMed ID: 28088657 [TBL] [Abstract][Full Text] [Related]
3. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Zhang SS; Yang H; Luo KJ; Huang QY; Chen JY; Yang F; Cai XL; Xie X; Liu QW; Bella AE; Hu RG; Wen J; Hu Y; Fu JH Br J Cancer; 2013 Nov; 109(11):2894-903. PubMed ID: 24201750 [TBL] [Abstract][Full Text] [Related]
4. Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy. Shridhar R; Hayman T; Hoffe SE; Weber J; Almhanna K; Chuong M; Karl RC; Meredith KL J Gastrointest Surg; 2012 Jul; 16(7):1296-302. PubMed ID: 22399271 [TBL] [Abstract][Full Text] [Related]
5. The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retrospective studies. Pan W; Sun Z; Xiang Y; Fang W Asia Pac J Clin Nutr; 2015; 24(3):480-8. PubMed ID: 26420190 [TBL] [Abstract][Full Text] [Related]
6. A high body mass index in esophageal cancer patients does not influence postoperative outcome or long-term survival. Blom RL; Lagarde SM; Klinkenbijl JH; Busch OR; van Berge Henegouwen MI Ann Surg Oncol; 2012 Mar; 19(3):766-71. PubMed ID: 21979112 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma. Sun P; Zhang F; Chen C; Ren C; Bi XW; Yang H; An X; Wang FH; Jiang WQ Onco Targets Ther; 2016; 9():6389-6397. PubMed ID: 27799787 [TBL] [Abstract][Full Text] [Related]
8. A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy. Miao L; Chen H; Xiang J; Zhang Y J Cancer Res Clin Oncol; 2015 May; 141(5):941-50. PubMed ID: 25428458 [TBL] [Abstract][Full Text] [Related]
9. High BMI has no impact on the survival of Chinese patients with lower thoracic esophageal adenocarcinoma treated with curative esophagectomy: a propensity score-matched study. Deng HY; Alai G; Li G; Luo J; Zhuo ZG; Lin YD Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29931316 [TBL] [Abstract][Full Text] [Related]
10. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection. Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096 [TBL] [Abstract][Full Text] [Related]
11. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Wang J; Myles B; Wei C; Chang JY; Hofstetter WL; Ajani JA; Swisher SG; Cox JD; Komaki R; Liao Z; Lin SH Dis Esophagus; 2014; 27(2):168-75. PubMed ID: 23621168 [TBL] [Abstract][Full Text] [Related]
12. Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: A 10-year medical experience. Ji W; Zheng W; Li B; Cao C; Mao W Medicine (Baltimore); 2016 Jul; 95(29):e4204. PubMed ID: 27442643 [TBL] [Abstract][Full Text] [Related]
13. Prediagnostic adult body mass index change and esophageal adenocarcinoma survival. Loehrer EA; Giovannucci EL; Betensky RA; Shafer A; Christiani DC Cancer Med; 2020 May; 9(10):3613-3622. PubMed ID: 32202699 [TBL] [Abstract][Full Text] [Related]
14. Lack of any prognostic value of body mass index for patients undergoing chemoradiotherapy for esophageal squamous cell carcinoma. Zhang F; Wang CS; Sun B; Tian GB; Cao FL; Cheng YF Asian Pac J Cancer Prev; 2014; 15(7):3075-9. PubMed ID: 24815450 [TBL] [Abstract][Full Text] [Related]
15. Body mass index, smoking, and alcohol and risks of Barrett's esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Yates M; Cheong E; Luben R; Igali L; Fitzgerald R; Khaw KT; Hart A Dig Dis Sci; 2014 Jul; 59(7):1552-9. PubMed ID: 24500448 [TBL] [Abstract][Full Text] [Related]
16. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Hayashi Y; Correa AM; Hofstetter WL; Vaporciyan AA; Rice DC; Walsh GL; Mehran RJ; Lee JH; Bhutani MS; Dekovich A; Swisher SG; Ajani JA Cancer; 2010 Dec; 116(24):5619-27. PubMed ID: 21136578 [TBL] [Abstract][Full Text] [Related]
17. Impact of Body Mass Index on Complications and Survival after Surgery for Esophageal and Gastro-Esophageal-Junction Cancer. Kruhlikava I; Kirkegård J; Mortensen FV; Kjær DW Scand J Surg; 2017 Dec; 106(4):305-310. PubMed ID: 28737095 [TBL] [Abstract][Full Text] [Related]
18. Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery. Ngamruengphong S; Wolfsen HC; Wallace MB Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1424-1429.e2; quiz e81. PubMed ID: 23735443 [TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. D'Journo XB; Ouattara M; Loundou A; Trousse D; Dahan L; Nathalie T; Doddoli C; Seitz JF; Thomas PA Dis Esophagus; 2012 Aug; 25(6):527-34. PubMed ID: 22121887 [TBL] [Abstract][Full Text] [Related]
20. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. Sinicrope FA; Foster NR; Yoon HH; Smyrk TC; Kim GP; Allegra CJ; Yothers G; Nikcevich DA; Sargent DJ J Clin Oncol; 2012 Feb; 30(4):406-12. PubMed ID: 22203756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]